Inhibrx Biosciences enters $150M loan facility
[ad_1]
Inhibrx Biosciences enters $150M loan facility
[ad_2]
[ad_1] Prysmian CEO says considering listing in the US – FT [ad_2]
[ad_1] Citigroup stock climbs after posting Q4 earning beat; announces $20B stock buyback [ad_2]
[ad_1] Costco blows past estimates with December sales tallies [ad_2]
[ad_1] Obesity drug developer Metsera files for $100M IPO [ad_2]
[ad_1] Ansys to sell PowerArtist business to Keysight Technologies [ad_2]
[ad_1] Fading spirits: American whiskey makers could face crippling demand, tariff headwinds [ad_2]